Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recon Technology (RCON) Liabilities and Shareholders Equity (2016 - 2025)

Recon Technology's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $76.3 million for Q2 2024.

  • For Q2 2024, Liabilities and Shareholders Equity changed 0.49% year-over-year to $76.3 million; the TTM value through Jun 2024 reached $226.6 million, up 27.5%, while the annual FY2024 figure was $76.7 million, 0.14% changed from the prior year.
  • Liabilities and Shareholders Equity for Q2 2024 was $76.3 million at Recon Technology, roughly flat from $75.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $76.3 million in Q2 2024 and bottomed at $27.4 million in Q2 2020.
  • The 4-year median for Liabilities and Shareholders Equity is $75.1 million (2022), against an average of $63.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 19.13% in 2020 before it increased 0.49% in 2024.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $27.4 million in 2020, then soared by 170.95% to $74.3 million in 2022, then rose by 2.14% to $75.9 million in 2023, then grew by 0.49% to $76.3 million in 2024.
  • Per Business Quant, the three most recent readings for RCON's Liabilities and Shareholders Equity are $76.3 million (Q2 2024), $75.9 million (Q2 2023), and $74.3 million (Q2 2022).